What does PHARMACIE LAIME do?

PHARMACIE LAIME is a pharmacy in Floreffe. Private Limited, started on 16 March 2009, 1 establishment.

What is the address of PHARMACIE LAIME?

The registered office of PHARMACIE LAIME is located at Rue Auguste-Renard 10, 5150 Floreffe.

Is PHARMACIE LAIME still active?

Yes. According to the CBE (31 October 2026) PHARMACIE LAIME is active, legal situation “Normale toestand”, started on 16 March 2009.

Is PHARMACIE LAIME registered on Peppol?

Yes, PHARMACIE LAIME is registered on the Peppol network with ID 0208:0810440839.

What is the enterprise number of PHARMACIE LAIME?

The enterprise number of PHARMACIE LAIME is BE0810440839.

When was PHARMACIE LAIME founded?

PHARMACIE LAIME was founded on 16 March 2009.

Who are the directors of PHARMACIE LAIME?

According to the 2024 annual accounts, the directors of PHARMACIE LAIME are: PHILIPPE LEMMENS, FREDERIQUE LAIME.

Is PHARMACIE LAIME a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 March 2009; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did PHARMACIE LAIME make in 2024?

PHARMACIE LAIME posted a profit after taxes of € 116,256 in financial year 2024.

What is the revenue of PHARMACIE LAIME?

As a small company, PHARMACIE LAIME is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 297,973.

How much does an employee at PHARMACIE LAIME earn?

The average wage cost per full-time employee at PHARMACIE LAIME was € 67,000 in 2024: staff costs of € 107,140 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE LAIME have?

According to the 2024 annual accounts, PHARMACIE LAIME has 1.6 full-time equivalents (FTE).

PHARMACIE LAIME (Private Limited) - Floreffe

Dossier PHARMACIE LAIME, printed on 31 October 2026 from databakkes.be/en/0810440839/pharmacie-laime. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

PHARMACIE LAIME from Floreffe, company number BE0810440839, closed financial year 2024 with a result of € 116,256 after tax. For that financial year PHARMACIE LAIME recorded a gross margin of € 297,973 and equity of € 545,213. Compared with financial year 2023, the result moved from € 107,045 to € 116,256. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2025.

What it is worth Healthy

€ 545,213

▼ 12% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 116,256

▲ 9% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 209,559

▲ 40% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 188,547 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Full-time equivalents

1.6

▲ 0.3 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 107,140

▲ 23% vs 2023

€ 67,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,583

▼ 44% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 49,806

▼ 25% vs 2023

€ 11,043 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 57,996

▼ 20% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 34,517

▼ 2% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 204,805 Gross margin 2021: € 204,805 First fiscal year in the series	€ 277,005 Gross margin 2022: € 277,005 ▲ 35% vs 2021 (€ 204,805) Favourable step	€ 254,281 Gross margin 2023: € 254,281 ▼ 8% vs 2022 (€ 277,005) Unfavourable step	€ 297,973 Gross margin 2024: € 297,973 ▲ 17% vs 2023 (€ 254,281) Favourable step	▲ 17%
Profit after taxes	€ 94,111 Profit after taxes 2021: € 94,111 First fiscal year in the series	€ 137,122 Profit after taxes 2022: € 137,122 ▲ 46% vs 2021 (€ 94,111) Favourable step	€ 107,045 Profit after taxes 2023: € 107,045 ▼ 22% vs 2022 (€ 137,122) Unfavourable step	€ 116,256 Profit after taxes 2024: € 116,256 ▲ 9% vs 2023 (€ 107,045) Favourable step	▲ 9%
Equity	€ 374,938 Equity 2021: € 374,938 First fiscal year in the series	€ 510,460 Equity 2022: € 510,460 ▲ 36% vs 2021 (€ 374,938) Favourable step	€ 617,504 Equity 2023: € 617,504 ▲ 21% vs 2022 (€ 510,460) Favourable step	€ 545,213 Equity 2024: € 545,213 ▼ 12% vs 2023 (€ 617,504) Unfavourable step	▼ 12%
Total debts	€ 283,963 Total debts 2021: € 283,963 First fiscal year in the series	€ 240,406 Total debts 2022: € 240,406 ▼ 15% vs 2021 (€ 283,963) Favourable step	€ 277,280 Total debts 2023: € 277,280 ▲ 15% vs 2022 (€ 240,406) Unfavourable step	€ 428,509 Total debts 2024: € 428,509 ▲ 55% vs 2023 (€ 277,280) Unfavourable step	▲ 55%
Cash	€ 285,687 Cash 2021: € 285,687 First fiscal year in the series	€ 156,159 Cash 2022: € 156,159 ▼ 45% vs 2021 (€ 285,687) Unfavourable step	€ 149,898 Cash 2023: € 149,898 ▼ 4% vs 2022 (€ 156,159) Unfavourable step	€ 209,559 Cash 2024: € 209,559 ▲ 40% vs 2023 (€ 149,898) Favourable step	▲ 40%
Retained profit	€ 356,338 Retained profit 2021: € 356,338 First fiscal year in the series	€ 491,860 Retained profit 2022: € 491,860 ▲ 38% vs 2021 (€ 356,338) Favourable step	€ 598,904 Retained profit 2023: € 598,904 ▲ 22% vs 2022 (€ 491,860) Favourable step	€ 526,613 Retained profit 2024: € 526,613 ▼ 12% vs 2023 (€ 598,904) Unfavourable step	▼ 12%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 1,600 Dividend 2022: € 1,600 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 1,600) Unchanged	€ 188,547 Dividend 2024: € 188,547 Unchanged (€ 0) Unchanged
Bank debt	€ 54,472 Bank debt 2021: € 54,472 First fiscal year in the series	€ 33,207 Bank debt 2022: € 33,207 ▼ 39% vs 2021 (€ 54,472) Favourable step	€ 66,535 Bank debt 2023: € 66,535 ▲ 100% vs 2022 (€ 33,207) Unfavourable step	€ 49,806 Bank debt 2024: € 49,806 ▼ 25% vs 2023 (€ 66,535) Favourable step	▼ 25%
Balance sheet total	€ 658,900 Balance sheet total 2021: € 658,900 First fiscal year in the series	€ 750,866 Balance sheet total 2022: € 750,866 ▲ 14% vs 2021 (€ 658,900) Unchanged	€ 894,785 Balance sheet total 2023: € 894,785 ▲ 19% vs 2022 (€ 750,866) Unchanged	€ 973,722 Balance sheet total 2024: € 973,722 ▲ 9% vs 2023 (€ 894,785) Unchanged	▲ 9%
Employees (FTE)	1.6 Employees (FTE) 2021: 1.6 First fiscal year in the series	1.5 Employees (FTE) 2022: 1.5 ▼ 0.1 vs 2021 (1.6) Unchanged	1.3 Employees (FTE) 2023: 1.3 ▼ 0.2 vs 2022 (1.5) Unchanged	1.6 Employees (FTE) 2024: 1.6 ▲ 0.3 vs 2023 (1.3) Unchanged	▲ 0.3

Key figures of PHARMACIE LAIME, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to PHARMACIE LAIME?

What happened at PHARMACIE LAIME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2025 New annual accounts for financial year 2024: profit of € 116,256 (▲ 9% vs 2023). filed late Source: NBB ↗
Apr 6, 2009 New establishment in Floreffe. KBO
2009 PHILIPPE LEMMENS became a director. NBB
2009 FREDERIQUE LAIME became a director. NBB
Mar 16, 2009 Start of the company according to the CBE. KBO

In short

From € 94,111 profit in 2021 to € 116,256 profit in 2024.

Paid € 187,201 in corporate taxes since 2021.

Best year ever: 2022, with € 137,122 profit.

On average € 186,200 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

PHILIPPE LEMMENS FREDERIQUE LAIME

PHARMACIE LAIME

Behind PHARMACIE LAIME are PHILIPPE LEMMENS and FREDERIQUE LAIME.

Directors

According to the 2024 annual accounts

PHILIPPE LEMMENS

Administrator-manager

since 2009

FREDERIQUE LAIME

Administrator-manager

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Auguste-Renard 10

5150 Floreffe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0810.440.839

VAT number

BE 0810.440.839

Registered office

Rue Auguste-Renard 10, 5150 Floreffe

Names & denominations

PHARMACIE LAIME

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 March 2009

Peppol

Active · Active since 12 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE LAIME

Financials

What happened to PHARMACIE LAIME?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions